Verition Fund Management LLC Verastem, Inc. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.92 - $11.16 $7,636 - $92,628
8,300 Added 42.24%
27,950 $24,000
Q2 2022

Aug 15, 2022
BUY
$1.02 - $1.83 $20,043 - $35,959
19,650 New
19,650 $23,000
Q2 2018

Aug 15, 2018
SELL
$2.88 - $8.67 $34,148 - $102,800
-11,857 Closed
0 $0
Q1 2018

May 16, 2018
BUY
$2.92 - $3.81 $34,622 - $45,175
11,857 New
11,857 $35,000

Others Institutions Holding VSTM

# of Institutions
5
Shares Held
297K
Call Options Held
0
Put Options Held
0
View Full List

About Verastem, Inc.

VSTM Quotes by TradingView
  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $1.24B
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email